GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Privia Health Group Inc (NAS:PRVA) » Definitions » Earnings per Share (Diluted)

Privia Health Group (Privia Health Group) Earnings per Share (Diluted) : $0.19 (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Privia Health Group Earnings per Share (Diluted)?

Privia Health Group's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was $0.02. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.19.

Privia Health Group's EPS (Basic) for the three months ended in Dec. 2023 was $0.02. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.19.

Privia Health Group's EPS without NRI for the three months ended in Dec. 2023 was $0.15. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $0.55.

During the past 3 years, the average EPS without NRIGrowth Rate was 28.20% per year.

During the past 6 years, Privia Health Group's highest 3-Year average EPS without NRI Growth Rate was 28.20% per year. The lowest was -293.60% per year. And the median was -132.70% per year.


Privia Health Group Earnings per Share (Diluted) Historical Data

The historical data trend for Privia Health Group's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Privia Health Group Earnings per Share (Diluted) Chart

Privia Health Group Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Earnings per Share (Diluted)
Get a 7-Day Free Trial 0.08 0.30 -1.83 -0.08 0.19

Privia Health Group Quarterly Data
Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.06 0.06 0.05 0.02

Competitive Comparison of Privia Health Group's Earnings per Share (Diluted)

For the Health Information Services subindustry, Privia Health Group's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Privia Health Group's PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Privia Health Group's PE Ratio distribution charts can be found below:

* The bar in red indicates where Privia Health Group's PE Ratio falls into.



Privia Health Group Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Privia Health Group's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(23.079-0)/124.686
=0.19

Privia Health Group's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (Q: Dec. 2023 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(2.838-0)/124.804
=0.02

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Privia Health Group  (NAS:PRVA) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Privia Health Group Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Privia Health Group's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Privia Health Group (Privia Health Group) Business Description

Traded in Other Exchanges
N/A
Address
950 N. Glebe Road, Suite 700, Arlington, VA, USA, 22203
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
Executives
William M Sullivan director ONE PENN PLAZA, SUITE 5300, NY NY 10119
Thomas Bartrum officer: EVP, General Counsel 950 N. GLEBE RD., SUITE 700, ALEXANDRIA VA 22203
Pamela O Kimmet director 11207 ORANGE HIBISCUS LANE, PALM BEACH GARDENS FL 33418
David S Wichmann director BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752
Parth Mehrotra officer: President and COO 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203
Adam Boehler director 1215 5TH AVE N,, NASHVILLE TN 37208
Matthew Shawn Morris director, officer: Chief Executive Officer 950 N. GLEBE ST., SUITE 700, ARLINGTON VA 22203
Goldman Sachs Group Inc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Jeffrey Daniel Bernstein director 200 WEST STREET, NEW YORK NY 10282
Pamplona Capital Partners Iii, L.p. 10 percent owner 94 SOLARIS AVENUE, CAMANA BAY, P.O. BOX 1348, GRAND CAYMAN E9 KY1-1108
Mbd Advisors, L.l.c. 10 percent owner 200 WEST STREET, NEW YORK NY 10282
David Mountcastle officer: Chief Financial Officer 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203
Jeffrey B Butler director 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22101
David P King director PRIVIA HEALTH GROUP, INC., 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203
Patricia Anne Maryland director 7342 HORIZON DRIVE, WEST PALM BEACH FL 33412